U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 132

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:87935517
GRCh38:
Chr16:87901911
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely pathogeniccriteria provided, single submitter
2.
GRCh37:
Chr16:87969974
GRCh38:
Chr16:87936368
CA5AM28KHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(May 30, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr16:87935498-87938530
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely pathogenic
(Jul 21, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr16:87960334-87960571
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(May 28, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr16:87936072
GRCh38:
Chr16:87902466
CA5AV172MHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr16:87960411
GRCh38:
Chr16:87926805
CA5AI95VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Feb 28, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr16:87925459
GRCh38:
Chr16:87891853
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jan 5, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr16:87925468
GRCh38:
Chr16:87891862
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jul 15, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr16:87960372
GRCh38:
Chr16:87926766
CA5AD108NHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Dec 20, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr16:87921736
GRCh38:
Chr16:87888130
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr16:87936063
GRCh38:
Chr16:87902457
CA5AN175DHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(May 9, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr16:87925447
GRCh38:
Chr16:87891841
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Oct 7, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr16:87935578
GRCh38:
Chr16:87901972
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not providedLikely benign
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr16:87925532
GRCh38:
Chr16:87891926
CA5AD216AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(May 3, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr16:87925480
GRCh38:
Chr16:87891874
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jun 24, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr16:87921866
GRCh38:
Chr16:87888260
CA5AR263CHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Jun 9, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr16:87960529
GRCh38:
Chr16:87926923
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Sep 17, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr16:87925469
GRCh38:
Chr16:87891863
CA5AP237LHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Apr 7, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr16:87925536
GRCh38:
Chr16:87891930
CA5AF215IHyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Inborn genetic diseasesUncertain significance
(Apr 20, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr16:87960516
GRCh38:
Chr16:87926910
CA5AG60RHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 13, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr16:87935535
GRCh38:
Chr16:87901929
CA5AP201THyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 8, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr16:87921786
GRCh38:
Chr16:87888180
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Mar 23, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr16:87925392
GRCh38:
Chr16:87891786
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Sep 20, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr16:87935508
GRCh38:
Chr16:87901902
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Mar 26, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr16:87969980
GRCh38:
Chr16:87936374
CA5AR26HCA5A-related condition, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Mar 6, 2023)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr16:87925543
GRCh38:
Chr16:87891937
CA5AM212IHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Jun 20, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr16:87938422
GRCh38:
Chr16:87904816
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Apr 2, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr16:87938381
GRCh38:
Chr16:87904775
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 22, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr16:87925515
GRCh38:
Chr16:87891909
CA5AP222SHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Jul 28, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr16:87936089
GRCh38:
Chr16:87902483
CA5AN166SInborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyConflicting interpretations of pathogenicity
(Dec 5, 2022)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr16:87936076
GRCh38:
Chr16:87902470
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Dec 22, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr16:87936140
GRCh38:
Chr16:87902534
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyBenign
(Jul 6, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr16:87938385
GRCh38:
Chr16:87904779
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jul 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr16:87921801
GRCh38:
Chr16:87888195
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 16, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr16:87936073
GRCh38:
Chr16:87902467
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jul 22, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr16:87921768
GRCh38:
Chr16:87888162
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Nov 23, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr16:87960509
GRCh38:
Chr16:87926903
CA5AT62IHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Dec 8, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr16:87925496
GRCh38:
Chr16:87891890
CA5AW228*Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyPathogenic
(Oct 14, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr16:87960439
GRCh38:
Chr16:87926833
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jul 18, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr16:87938464
GRCh38:
Chr16:87904858
CA5AF129LHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 3, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr16:87960545
GRCh38:
Chr16:87926939
CA5AP50QHyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not specifiedUncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr16:87925405
GRCh38:
Chr16:87891799
CA5AQ258HHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr16:87960507
GRCh38:
Chr16:87926901
CA5AR63WHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr16:87936078
GRCh38:
Chr16:87902472
CA5AA170SHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Dec 28, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr16:87921871
GRCh38:
Chr16:87888265
CA5AA261VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr16:87938447
GRCh38:
Chr16:87904841
CA5AA135VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Oct 31, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr16:87925561-87970113
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely pathogenic
(Aug 29, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr16:87925549
GRCh38:
Chr16:87891943
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jan 18, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr16:87921865
GRCh38:
Chr16:87888259
CA5AR263HHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyConflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr16:87935548
GRCh38:
Chr16:87901942
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jan 8, 2021)
criteria provided, single submitter
51.
GRCh37:
Chr16:87925426
GRCh38:
Chr16:87891820
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Sep 27, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr16:87936019
GRCh38:
Chr16:87902413
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyBenign
(Sep 1, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr16:87938413
GRCh38:
Chr16:87904807
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jun 27, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr16:87938382
GRCh38:
Chr16:87904776
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Oct 27, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr16:87960338
GRCh38:
Chr16:87926732
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 6, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr16:87921876
GRCh38:
Chr16:87888270
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Sep 21, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr16:87960347
GRCh38:
Chr16:87926741
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 6, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr16:87925567
GRCh38:
Chr16:87891961
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jun 13, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr16:87921807
GRCh38:
Chr16:87888201
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Oct 24, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr16:87925453
GRCh38:
Chr16:87891847
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(May 12, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr16:87970039
GRCh38:
Chr16:87936433
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jun 20, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr16:87960441
GRCh38:
Chr16:87926835
CA5AV85FHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 19, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr16:87935580
GRCh38:
Chr16:87901974
CA5AL186VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Dec 2, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr16:87970019
GRCh38:
Chr16:87936413
CA5AS13FHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Mar 13, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr16:87938418
GRCh38:
Chr16:87904812
CA5AV145MInborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 23, 2023)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr16:87936072
GRCh38:
Chr16:87902466
CA5AV172LInborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyConflicting interpretations of pathogenicity
(Mar 2, 2023)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr16:87936042
GRCh38:
Chr16:87902436
CA5AV182MHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Oct 20, 2021)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr16:87938475
GRCh38:
Chr16:87904869
CA5AL126VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr16:87925435
GRCh38:
Chr16:87891829
CA5AQ248HHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr16:87925556
GRCh38:
Chr16:87891950
CA5AA208VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 20, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr16:87960530
GRCh38:
Chr16:87926924
CA5AP55LHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr16:87938407
GRCh38:
Chr16:87904801
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Jul 5, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr16:87960334-87970056
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyPathogenic
(Aug 23, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr16:87969934
GRCh38:
Chr16:87936328
CA5AW41CHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr16:87925553
GRCh38:
Chr16:87891947
CA5AR209QHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Nov 8, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr16:87935521
GRCh38:
Chr16:87901915
CA5AH205QInborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr16:87938439
GRCh38:
Chr16:87904833
CA5AE138KHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Dec 12, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr16:87925511
GRCh38:
Chr16:87891905
CA5AT223NInborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr16:87938406
GRCh38:
Chr16:87904800
CA5AA149THyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Inborn genetic diseasesUncertain significance
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr16:87921805-87921806
GRCh38:
Chr16:87888199-87888200
CA5AP283EHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Sep 16, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr16:87938405
GRCh38:
Chr16:87904799
CA5AA149VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Sep 6, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr16:87925416
GRCh38:
Chr16:87891810
CA5AA255THyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr16:87960396
GRCh38:
Chr16:87926790
CA5AY100NHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Sep 18, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr16:87960459
GRCh38:
Chr16:87926853
CA5AQ79EInborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(May 20, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr16:87969968
GRCh38:
Chr16:87936362
CA5AP30RHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr16:87960407
GRCh38:
Chr16:87926801
CA5AW96Snot provided, Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
Uncertain significance
(Mar 2, 2023)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr16:87921834
GRCh38:
Chr16:87888228
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(May 18, 2019)
criteria provided, single submitter
88.
GRCh37:
Chr16:87960558-87960559
GRCh38:
Chr16:87926952-87926953
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 26, 2019)
criteria provided, single submitter
89.
GRCh37:
Chr16:87921804
GRCh38:
Chr16:87888198
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Oct 14, 2020)
criteria provided, single submitter
90.
GRCh37:
Chr16:87925489
GRCh38:
Chr16:87891883
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely benign
(Aug 15, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr16:87938372-87960571
CA5AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyPathogenic
(Mar 5, 2020)
criteria provided, single submitter
92.
GRCh37:
Chr16:87636753-88505740
BANP, CA5A, JPH3, KLHDC4, SLC7A5, ZNF469Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyPathogenic
(Oct 10, 2020)
criteria provided, single submitter
93.
GRCh37:
Chr16:87936074
GRCh38:
Chr16:87902468
CA5AV171AHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr16:87935561
GRCh38:
Chr16:87901955
CA5AT192MHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Oct 25, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr16:87938424
GRCh38:
Chr16:87904818
CA5AH143DHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr16:87925550
GRCh38:
Chr16:87891944
CA5AA210VHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr16:87935556
GRCh38:
Chr16:87901950
CA5AQ194*Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyLikely pathogeniccriteria provided, single submitter
98.
GRCh37:
Chr16:87925392-87925412
GRCh38:
Chr16:87891786-87891806
CA5Anot provided, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not specified
Conflicting interpretations of pathogenicity
(Apr 14, 2023)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr16:87936113
GRCh38:
Chr16:87902507
CA5AH158PHyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not providedUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr16:87960423
GRCh38:
Chr16:87926817
CA5AS91PHyperammonemic encephalopathy due to carbonic anhydrase VA deficiencyUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination